(Q73532358)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

M C Tellier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Soos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Pu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D Pollock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J K Yamamoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

number of pages

11

1 reference

inferred from page(s)

published in

Veterinary Microbiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Immunological adjuvants: Desirable properties and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Immunogenicity of a viral model vaccine after different inactivation procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Induction of protective cytotoxic T cells with viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Effect of a Membrane-Active Agent on Uptake of Adriamycin in Lewis Lung Carcinoma Cells Derived from ‘Primary’ and ‘Metastatic’ Growths

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Potential use of non-replicating vectors as recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Passive antibody protection of cats against feline immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

A formalin-inactivated whole SIV vaccine confers protection in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Vaccinia virus as an expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Characterization of simian immunodeficiency virus-specific T-cell-mediated cytotoxic response of infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Current status of immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Transport methods for probing the barrier domain of lipid bilayer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Experimental vaccine protection against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Development of IL-2 Independent Feline Lymphoid Cell Lines Chronically Infected with Feline Immunodeficiency Virus: Importance for Diagnostic Reagents and Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2897%2900081-3

7 January 2021

10.1016/S0378-1135(97)00081-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9231977%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference